جست‌وجوی استاد و پژوهشگر

Camila Aquinoمشاهده پروفایل

استادیار

• Movement Disorders
• Parkinson's Disease
• Deep Brain Stimulation
• +۵ مورد دیگر

Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.

• Health services for older people
• Collaborative models of care
• Frailty
• +۴ مورد دیگر

Janani Thillainadesan is an NHMRC Senior Research Fellow at the Sydney Medical School/Concord Clinical School and the Centre for Education and Research on Ageing, affiliated with the Faculty of Medicine and Health at the University of Sydney. She is also a member of the Charles Perkins Centre. Her research focuses on optimizing healthcare delivery for older adults, particularly in geriatric surgery, perioperative care, and dementia interventions. Key research areas include frailty assessment, deprescribing strategies, collaborative care models, and leveraging technology (e.g., mobile health) in geriatric medicine. She has contributed to multidisciplinary studies involving clinical datasets, quality indicators, and mixed-methods analyses of patient experiences and care expectations. Awards: 2023 RACP Vincent Fairfax Research Fellowship 2021 ANZSGM Career Investigator Prize 2021 UK Age Anaesthesia Association Best Oral Presentation Prize 2019 Evidence Based Perioperative Medicine Asia Congress Runner Up Prize Her work bridges clinical practice, education, and policy through grants like the 2024 electronic frailty index project. Media engagement includes a 2019 Studio 10 segment highlighting her contributions to aging-related healthcare innovations.

Eileen Kleinمشاهده پروفایل

دانشیار

• Community Mental Health
• LGBTQ Mental Health Treatment
• Social Work Policy Advocacy
• +۳ مورد دیگر

Eileen Klein is an Associate Professor of Social Work and Convener of the BSW Program at Ramapo College of New Jersey's School of Social Science and Human Services. Her work focuses on LGBTQ mental health treatment , community support systems , and policy reform for marginalized populations. Klein has presented extensively at international conferences on topics like cultural competency in social work education and LGBTQ health disparities . Ph.D., M.S., and M.S.W. from New York University and SUNY Buffalo Key research areas: LGBTQ Mental Health, Community Health Disparities, Forensic Social Work Published 15+ works (2013-2021) on topics ranging from polypharmacy to support programs for LGBTQ clients Active in professional development: Delivered presentations at conferences across the U.S. and Italy on topics including integrated treatment and supervision of student interns

David Alldredمشاهده پروفایل

استاد

• Medicines Optimisation
• Patient Safety
• Deprescribing
• +۵ مورد دیگر

Professor David Alldred is a Professor of Medicines Use and Safety at the University of Leeds' School of Healthcare, within the Faculty of Medicine and Health. His expertise spans medicines optimisation, patient safety, deprescribing, and care home medication management. He leads key research initiatives such as the NIHR Yorkshire and Humber Patient Safety Research Collaboration's 'Decluttering Safely for Safety' theme and co-leads the School of Healthcare's Quality and Safety research theme. Education: PhD (clinical research on care home medication review), MSc in Clinical Pharmacy, PGCert in Learning and Teaching, and BPharm (Hons). Professional memberships include Fellowships of the Royal Pharmaceutical Society and the Higher Education Academy. Research focuses on improving medication use for older adults in care homes and underserved populations, employing systematic reviews, qualitative studies, and RCTs. Notable projects include the CHUMS study (Department of Health-funded medication error analysis in care homes) and leadership roles in NIHR Programme Grants like CHIPPS and CHARMER. He collaborates with NHS England to implement medicines optimisation programs and co-designed multilingual medication review resources to reduce health inequalities. Awards include the Pharmacy Practice UK Research Award (2015) and NIHR Senior Investigator status (2025). His work emphasizes translating evidence into clinical practice, with over 150 publications and supervising NIHR-funded doctoral students in critical care, diabetes, cystic fibrosis, and geriatrics. Led the Care Homes' Use of Medicines Study (CHUMS), contributed to NICE guidelines for care home medicines management, and developed interventions like the Medicines at Transitions Intervention (MaTI) for heart failure patients. His research themes address polypharmacy reduction, medication safety across care transitions, and pharmacist-led deprescribing strategies.

• Geriatric Pharmacology
• Deprescribing
• Pharmacoepidemiology
• +۳ مورد دیگر

Nashwa Masnoon is a Postdoctoral Research Fellow in Geriatric Pharmacotherapy at the Kolling Institute, part of the Faculty of Medicine and Health at the University of Sydney. She is also a hospital pharmacist at the Royal North Shore Hospital. Her academic background includes a BPharm(Hons) and a PhD from the University of South Australia, where her doctoral work focused on identifying risks of adverse outcomes from polypharmacy in older adults with multimorbidity. Dr Masnoon’s research interests span geriatric pharmacology, deprescribing practices, pharmacoepidemiology, and quality use of medicines. Her current projects include developing stewardship programs for anticholinergic/sedative deprescribing, optimizing medication use in hospitals for older patients, and educating hospital pharmacists using the Drug Burden Index intervention bundle. She has co-supervised Honours students in 2022 and 2023, focusing on deprescribing in hospital settings and patient-reported experiences post-intervention. Research Themes: Healthy Ageing Key Approaches: Systematic reviews, clinical interventions, pharmacoepidemiological analysis Dr Masnoon has received notable awards including the 2023 FMH Showcase Travel Award, Royal North Shore Hospital Travel Fellowship (2023), and a 2017 People’s Choice Award for her 3 Minute Thesis presentation. Her work emphasizes improving medication outcomes through evidence-based deprescribing and precision medicine approaches. She is affiliated with the Australasian Pharmaceutical Science Association (APSA), International Pharmaceutical Federation (FIP), and Australian Deprescribing Network (ADeN). Her grants include the 2024 electronic frailty index project and a 2022 travel award-funded initiative.

• Pharmacy Practice
• Medication Management
• Osteoporosis Care
• +۷ مورد دیگر

Associate Professor Stephen Carter is an Associate Professor in Pharmacy Practice at the University of Sydney's Sydney Pharmacy School within the Faculty of Medicine and Health. He serves as the Program Director for Undergraduate Pharmacy programs and is a registered pharmacist with clinical specialisation in medication management review. Stephen holds qualifications including BPharm, MSc, PhD, and Grad Cert Edu (Higher Ed). He is a Fellow of the Pharmaceutical Society of Australia (FPS), Fellow of the Higher Education Academy (FHEA), and holds other professional accreditations. His research focuses on optimizing the role of pharmacists in healthcare, particularly examining how consumers and caregivers obtain and use medicines, designing effective pharmacist services, and supporting pharmacists throughout their professional journey. His work spans areas including osteoporosis care, medication adherence, service quality in community pharmacies, and the application of advanced statistical methods like Structural Equation Modelling. Stephen's publications demonstrate a strong focus on practical pharmacy interventions, with significant work on osteoporosis management services, perinatal depression screening in pharmacies, and digital health approaches to improve medication adherence. His research employs diverse methodologies including randomized controlled trials, qualitative studies, and advanced psychometric analyses. Early Career Investigator Award Australasian Pharmaceutical Science Association (APSA) for 2017 Lesmuller Award for Best Oral Communication - Pharmaceutical Care Network Europe Working Conference, Berlin, 2013 Recipient of the 2013 Annual Best Paper Award by Elsevier publication, Research in Social and Administrative Pharmacy Best Poster Presentation Award: International Social Pharmacy Workshop, Boston, USA, 2014 Top reviewer, Research in Social and Administrative Pharmacy (2015, 2016, 2017, 2019) Stephen actively supervises several graduate students including PhD candidates Fatima Rezea, Steven Tran, Veronika Seda, Kingston Leung, and Joel Hillman, as well as MPhil student Linda Krogh. He has secured significant research funding, including co-leading a $2.36 million Randomized Controlled Trial and managing four current competitive grant-funded projects totaling over $6.3 million. His work has particular emphasis on translating research into practical pharmacy services that improve patient outcomes. Stephen is actively involved in major research initiatives including the #STOP trial (Safer medicines To reduce falls and refractures for OsteoPorosis) and the TICTOC trial (Timely post-discharge medication reviews to Improve Continuity – the Transitions Of Care stewardship), both focusing on innovative pharmacist-led interventions to improve medication safety and effectiveness.

• Public Policy
• Health Economics
• Substance Use
• +۳ مورد دیگر

Ashley Bradford is an Assistant Professor at the School of Public Policy within Georgia Tech's Ivan Allen College of Liberal Arts. Her research focuses on the economics of risky behaviors, substance use, and the impact of public policies on health outcomes in the U.S., particularly examining drug policy innovations and housing policy intersections. She holds a Ph.D. in Public Affairs from Indiana University, an MPA from the University of Georgia, and a B.A. in Sociology from the same institution. Her work bridges policy analysis and health economics, with recent studies addressing opioid reformulations, cannabis legalization effects on mental health treatment, and the interplay between evictions and healthcare outcomes. Her research has been published in high-impact journals such as Health Affairs and JAMA Internal Medicine , and featured in major media outlets like The New York Times and Forbes . Bradford joined Georgia Tech in 2023, continuing her focus on policy interventions to address systemic issues in healthcare access, addiction treatment, and housing stability. Her interdisciplinary approach combines rigorous quantitative analysis with real-world policy applications.

• Clinical Informatics
• Emergency Medicine
• Electronic Health Records
• +۵ مورد دیگر

Mark Iscoe, MD, MHS is an Assistant Professor of Emergency Medicine and Biomedical Informatics and Data Science at Yale School of Medicine. He holds fully joint appointments in both the Department of Emergency Medicine and the Department of Biomedical Informatics & Data Science, reflecting his interdisciplinary work at the critical intersection of clinical emergency care and health informatics innovation. Dr. Iscoe completed his medical degree at Johns Hopkins University School of Medicine in 2017, followed by residency training in Emergency Medicine at New York University / Bellevue Hospital in 2021. He further specialized with a Master of Health Science (MHS) in Clinical Informatics from Yale School of Medicine in 2023. He is board certified in both Emergency Medicine (2022) and Clinical Informatics (2024). His research spans several interconnected domains with a focus on optimizing the interface between emergency physicians and health information technology. Key areas include electronic health record (EHR) optimization, artificial intelligence applications in emergency settings, clinical decision support systems, and medication safety protocols. His 2024 JAMA Network Open publication 'Benchmarking Emergency Physician EHR Time per Encounter Based on Patient and Clinical Factors' represents a significant contribution to understanding the digital burden on emergency clinicians. More recently, he has pioneered work applying large language models to emergency medicine challenges, with multiple 2025 publications on AI applications for deprescribing, symptom identification, and risk stratification. His research trajectory shows a clear evolution from foundational EHR usage studies toward increasingly sophisticated AI implementations that bridge theoretical informatics with practical clinical tools in high-pressure emergency settings. YCCI Scholar Award for AI Research on Drug Reactions (2024) Dr. Iscoe has received research funding from multiple prestigious sources including the National Institute on Drug Abuse (NIDA), the American Medical Association (AMA), the National Institutes of Health, and Yale New Haven Health System. His collaborative network includes prominent researchers such as Andrew Taylor (6 joint publications), Ted Melnick (5 joint publications), and Rohit Sangal (4 joint publications), reflecting his work's multidisciplinary nature spanning clinical departments, informatics specialists, and data scientists.

Maria Eriksdotterمشاهده پروفایل

استاد

• Alzheimer's Disease
• Geriatrics
• Dementia
• +۶ مورد دیگر

Professor Maria Eriksdotter is a leading academic in geriatrics and dementia research at the Karolinska Institutet , holding the Department of Neurobiology, Care Sciences and Society . She also serves as a Senior Consultant in Themes Inflammation and Ageing at Karolinska University Hospital Huddinge and previously as Dean of KI South (2019–2023). Her work spans translational research, clinical trials, and national registry development, with a focus on Alzheimer's disease, cholinergic therapies, and aging. Her research group pioneered NGF cell therapy for Alzheimer's patients, demonstrating safety and cognitive stabilization in clinical trials. She chairs the SveDem registry , tracking over 100,000 dementia patients to refine diagnostics and care. Studies from SveDem revealed mortality reduction with cholinesterase inhibitors and highlighted pandemic-era diagnostic delays. Recent publications analyze dementia subtypes , comorbidities , and precision medicine in neurodegeneration. Her work intersects neuroimaging , epidemiology , and public health policy , addressing ageism and improving geriatric care systems. Collaborations span Karolinska University Hospital , NSGene Inc , and international institutions.

Emily Callanderمشاهده پروفایل

استاد

• Health Economics
• Women's Health
• Maternal Health
• +۱۱ مورد دیگر

Emily Callander is a Professor of Women’s Health Economics at the Monash Centre for Health Research and Implementation, Monash University, and Head of Discipline in Health Services Management at the University of Technology Sydney (UTS). She leads the Women’s Economics and Value Based Care research program and holds leadership roles in national health policy, including as Vice President of Women's Healthcare Australasia and member of the Pharmaceutical Benefits Advisory Committee Economics Subcommittee. BA in Economics and Policy, Griffith University PhD in Health Economics, University of Sydney Postdoctoral training at NHMRC Clinical Trials Centre and Charles Perkins Centre, University of Sydney Her research focuses on maternal and women's health, utilizing linked administrative data, economic evaluation, and modelled analysis to influence health policy and delivery. Her work spans efficient staffing models, rural health access, national maternity initiatives (e.g., Safer Baby Bundle, Normal Birth Strategy), and cost analyses for global maternal health programs supported by the Gates Foundation. Her recent publications reflect a strong trend in health economic evaluations of maternity care models, medication use in pregnancy, digital health implementation, and preterm birth prevention. These works emphasize real-world applicability, equity, and cost-effectiveness, aligning with her mission to embed economic evidence into health systems. She has been supported by prestigious NHMRC awards, including a Doctoral Scholarship, Early Career Fellowship, and Career Development Fellowship. Her scientific contributions are recognized through active research projects and expert media commentary on maternity care policy. NHMRC Doctoral Scholarship NHMRC Early Career Fellowship NHMRC Career Development Fellowship Emily Callander advises on multiple national and international research projects, often as Chief or Associate Investigator, and collaborates with institutions such as Coventry University. She is actively accepting PhD students and contributes to policy through advisory roles in government and non-profit organizations. Her research is supported by grants from NHMRC, government departments, and international foundations. She leads the Women’s Economics and Value Based Care program at Monash and is a key member of the Transforming Maternity Care Collaborative. Her work is embedded in real-world health systems, partnering with consumers, providers, and policymakers to improve women’s health outcomes globally.

• Clinical Pharmacology
• Quality Use of Medicines
• Geriatric Pharmacology
• +۳ مورد دیگر

Professor Andrew McLachlan is the Head of School and Dean of Pharmacy at the Sydney Pharmacy School, University of Sydney. He holds a BPharm(Hons1 Medal) and PhD, and is a Member of the Order of Australia (AM). His research focuses on clinical pharmacology, particularly optimizing medication use in special populations such as older adults, children, and critically ill patients. He has led initiatives like the NHMRC Centre for Research Excellence in Medicines and Ageing, and his work emphasizes translating clinical evidence into real-world practice. Education: Bachelor of Pharmacy (First Class Honours) PhD in Clinical Pharmacology Research Interests: Variability in drug response across populations Quality use of medicines in geriatrics Pharmacotherapy optimization in critical care Deprescribing strategies for older adults Grants & Projects: PROSPER Trial (2025): Evaluating opioid alternatives for postoperative pain DREAM Trial (2024): Duloxetine for chronic sciatica Awards: Member of the Order of Australia (AM) Key Contributions: Leading deprescribing initiatives Advancing personalized pharmacotherapy Improving medication safety in vulnerable populations

• Digital Health
• Human-Computer Interaction (HCI)
• User-Centered Design
• +۱۱ مورد دیگر

Professor Marilyn Lennon is a leading academic in the Department of Computer and Information Sciences at the University of Strathclyde , holding the title of Professor in Digital Health and Care. She founded and directs the Digital Health and Wellness Group (DHaWG) , focusing on multidisciplinary research for designing, evaluating, and implementing digital technologies that enhance individual and population health and wellbeing. First class BSc in Psychology (University of Glasgow, 1998) PhD in Computing Science (University of Glasgow, 2002) Postgraduate diploma in academic practice (Fellow of Higher Education Academy) With over two decades of experience in Human-Computer Interaction (HCI) , usability, and user-centered design, her research spans wearable and mobile technologies for home healthcare, including remote monitoring (predictive falls monitoring), remote diagnosis (colon capsule technology evaluations), and smart home solutions for social care. She specializes in addressing technical and social barriers to real-world health technology implementation, emphasizing robust yet rapid evaluation methods. Recent publications highlight her work in 3D healthcare visualization, telehealth implementation, and medication management systems. Her research combines lab-based usability testing with real-world ('in the wild') evaluations of technologies like smart home systems and telehealth solutions. Key trends include cross-disciplinary collaboration, accessibility for sensory-impaired individuals, and AI-driven healthcare innovations. Scientific Awards MyCity: Glasgow - Gamechanger Award (Gold Medal) 2025 Images of Research 2025 Shortlist Emerald Outstanding Paper Award 2013 Best Paper Award (most replicable scientific paper) 2013 As course director for the Masters in Digital Health Systems , she has supervised 5 PhD students (2 completed) and over 100 honors projects. Current projects include the No Need to Fall initiative funded by the Health Foundation (£400k) and the PREMIO project co-creating clinical trials in advanced breast cancer. She maintains active collaborations with NHS, charities, and international institutions like the University of Waterloo.

Emily Reeveمشاهده پروفایل

عضو هیئت علمی

• Deprescribing
• Polypharmacy
• Geriatrics
• +۳ مورد دیگر

Emily Reeve is a Senior Research Fellow at Monash University's Centre for Medicine Use and Safety, focusing on deprescribing and polypharmacy. She holds an NHMRC Investigator Grant (2021-2025) and has held fellowships including an NHMRC-ARC Dementia Research Development Fellowship. Her work addresses medication optimization in older adults, particularly those with dementia or frailty. Education: PhD from University of South Australia (2014), postdoctoral research at University of Sydney and Dalhousie University (Canada). She also completed a visiting research stint at the Brocher Foundation (Switzerland). Research Interests: Deprescribing strategies and guidelines Polypharmacy reduction in geriatric populations Pharmacy practice innovation Health services research in dementia care Projects: Current initiatives include leading the 'Educating health professionals through a Knowledge Transfer Framework' project and co-investigating deprescribing safety via the GEODES project. Awards: Medal from School of Pharmacy and Medical Sciences (2014). Grants: NHMRC Investigator Grant (EL2), NHMRC-ARC Fellowship. Labs/Teams: Collaborates with global networks including the NHMRC Cognitive Decline Partnership Centre and the Dalhousie University Department of Medicine.

Debbie Kellyمشاهده پروفایل

استاد

• Pharmacist scope of practice
• Collaborative models of care
• Health outcomes research
• +۹ مورد دیگر

Dr. Debbie Kelly is a Professor and Special Advisor for Practice Innovation at Memorial University's School of Pharmacy, where she also serves as Director of the Medication Therapy Services Clinic (MTS Clinic). She holds cross-appointments with the Faculty of Medicine and Eastern Health's Provincial HIV Program, functioning as Clinical Pharmacotherapy Specialist to the provincial HIV program. Dr. Kelly's educational background includes: Bachelor of Science in Pharmacy from Memorial University (1996) Hospital pharmacy residency from Queen Elizabeth II Health Science Centre in Halifax (1997) Doctor of Pharmacy from the University of Toronto (1999) Dr. Kelly established Newfoundland and Labrador's first pharmacist clinic (the MTS Clinic) in 2016 and has built a significant research program around pharmacist scope of practice, collaborative care models, and health outcomes. Her work focuses on optimizing medication use, deprescribing, and expanding pharmacists' roles in HIV care, sexual health services, and point-of-care testing. A pivotal moment in her career came in 2009 when she co-established Canada's first nurse practitioner-pharmacist-led HIV clinic following the province's loss of its only infectious disease physician. Her recent publications demonstrate a strong emphasis on evaluating pharmacist-led models for HIV prevention, sexual health services, and medication optimization, particularly in rural and underserved communities where up to a third of patients lack family doctors. The research consistently shows pharmacists can effectively expand access to care, reduce emergency department visits, and improve health outcomes. Dr. Kelly has received numerous prestigious awards, including: 2025 Canadian Pharmacist of the Year from the Canadian Pharmacists Association 2025 Canadian Pharmacists Journal Best Paper of the Year 2024 James C. Quick Award 2020 CNIE Award of Merit for Excellence in Instructional Design Multiple Bristol Myers Squibb Excellence in Pharmaceutical Teaching awards She actively mentors PhD and Master's students working on projects related to hepatitis C testing, HIV services, and deprescribing. Her research is supported by significant CIHR grants including ACCESS-Rx, APPROACH 2.0, and CTN+. Dr. Kelly is currently focused on scaling the MTS Clinic model across Newfoundland and Labrador, integrating pharmacists into public health testing systems, and advocating for expanded pharmacist scope of practice aligned with their education to address healthcare gaps, particularly in rural communities.

• Acquired Immune Deficiency Syndrome (AIDS)
• Chronic Disease Management
• Healthcare System Structures
• +۷ مورد دیگر

Dr. Ira B. Wilson is the Associate Provost for Academic Space (2023–present) and Professor of Health Services, Policy and Practice at Brown University’s School of Public Health, as well as Professor of Medicine at Alpert Medical School. He holds dual roles in academic administration and public health research, with a focus on healthcare systems and HIV/AIDS. His career includes leadership roles at Tufts Medical Center and Brown University, where he chaired the Department of Health Services, Policy and Practice from 2010–2023. He currently co-directs the Providence/Boston Center for AIDS Research’s Professional Development Core and leads Rhode Island’s Clinical and Translational Research initiatives. His research examines how healthcare structures influence patient interactions and outcomes, particularly for chronic conditions like HIV and depression. Despite stepping back from active funded research in 2023, he continues teaching PHP 310 ("Health Care in the United States") and mentoring students. Notable roles include co-chairing the NIH-funded Behavioral Science Advisory Group for HIV clinical trials and advising Rhode Island’s Medicaid reform efforts. Education: Harvard College (undergraduate), Harvard Medical School (MD), and a Sc.M. in Epidemiology from the Harvard School of Public Health. Residency and fellowships at Beth Israel Hospital, Boston. Research Interests: Structural features of healthcare systems, physician-patient dynamics, medication adherence, HIV/AIDS care, quality improvement, and healthcare policy. Active in global health initiatives in Kenya and South Africa. Recent Work: Focuses on medication adherence strategies, HIV aging, and policy reforms. Recent publications address opioid harm reduction, nursing home care quality, telehealth during the pandemic, and disparities in Medicaid coverage. Grants & Leadership: Directed NIH-funded CFAR and IDeA-CTR cores. Active on national HIV advisory boards, including the HIV Medicine Association’s board. Appointed by Rhode Island’s governor to lead Medicaid reform initiatives. Labs/Teams: Leads interdisciplinary teams in the Brown School of Public Health, emphasizing collaboration between clinical and policy researchers.